SENATE DOCKET, NO. 1265 FILED ON: 1/18/2013
SENATE . . . . . . . . . . . . . . No. 907
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Benjamin B. Downing
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act regulating the use of buprenorphine in opioid dependence treatment.
_______________
PETITION OF:
Name: | District/Address: |
Benjamin B. Downing | Berkshire, Hampshire, Franklin and Hampden |
John F. Keenan | Norfolk and Plymouth |
William Smitty Pignatelli | 4th Berkshire |
SENATE DOCKET, NO. 1265 FILED ON: 1/18/2013
SENATE . . . . . . . . . . . . . . No. 907
By Mr. Downing, a petition (accompanied by bill, Senate, No. 907) of Benjamin B. Downing, John F. Keenan and William Smitty Pignatelli for legislation relative to the use of buprenorphine in opioid dependence treatment. Mental Health and Substance Abuse. |
The Commonwealth of Massachusetts
_______________
In the Year Two Thousand Thirteen
_______________
An Act regulating the use of buprenorphine in opioid dependence treatment.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1: Notwithstanding any general or special law to the contrary, the department of public health shall promulgate regulations relative to the use of buprenorphine and its variants in the treatment of opioid dependence. Said regulations shall include, but not be limited to: requiring prescribing entities to conduct routine toxicology screens of clients, pill call-backs, maximum take-home dosages, and any other regulations deemed necessary to limit diversion of buprenorphine and its variants.